These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 16272614

  • 21. PPAR alpha, fibrates, lipid metabolism and inflammation.
    Duval C, Fruchart JC, Staels B.
    Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
    [Abstract] [Full Text] [Related]

  • 22. [Anti-inflammatory action of PPARs].
    Fujii H.
    Nihon Rinsho; 2005 Apr; 63(4):609-15. PubMed ID: 15828228
    [Abstract] [Full Text] [Related]

  • 23. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.
    Gardner OS, Dewar BJ, Graves LM.
    Mol Pharmacol; 2005 Oct; 68(4):933-41. PubMed ID: 16020742
    [Abstract] [Full Text] [Related]

  • 24. Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes.
    Tan NS, Michalik L, Desvergne B, Wahli W.
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):99-105. PubMed ID: 15860251
    [Abstract] [Full Text] [Related]

  • 25. [The structures and functions of peroxisome proliferator-activated receptors (PPARs)].
    Takahashi N, Goto T, Kusudo T, Moriyama T, Kawada T.
    Nihon Rinsho; 2005 Apr; 63(4):557-64. PubMed ID: 15828220
    [Abstract] [Full Text] [Related]

  • 26. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM, Schiffrin EL.
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [Abstract] [Full Text] [Related]

  • 27. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
    Sertznig P, Seifert M, Tilgen W, Reichrath J.
    J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
    [Abstract] [Full Text] [Related]

  • 28. PPARs at the crossroads of lipid signaling and inflammation.
    Wahli W, Michalik L.
    Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
    [Abstract] [Full Text] [Related]

  • 29. Peroxisome proliferator-activated receptors (PPARs) and their agonists for hypertension and heart failure: are the reagents beneficial or harmful?
    Chen R, Liang F, Moriya J, Yamakawa J, Takahashi T, Shen L, Kanda T.
    Int J Cardiol; 2008 Nov 12; 130(2):131-9. PubMed ID: 18582964
    [Abstract] [Full Text] [Related]

  • 30. PPARs and the kidney in metabolic syndrome.
    Ruan X, Zheng F, Guan Y.
    Am J Physiol Renal Physiol; 2008 May 12; 294(5):F1032-47. PubMed ID: 18234957
    [Abstract] [Full Text] [Related]

  • 31. The selected pathophysiological aspects of PPARs activation.
    Kieć-Wilk B, Dembińska-Kieć A, Olszanecka A, Bodzioch M, Kawecka-Jaszcz K.
    J Physiol Pharmacol; 2005 Jun 12; 56(2):149-62. PubMed ID: 15985699
    [Abstract] [Full Text] [Related]

  • 32. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
    Andrééva-Gatéva P.
    Ann Biol Clin (Paris); 2003 Jun 12; 61(3):295-303. PubMed ID: 12805006
    [Abstract] [Full Text] [Related]

  • 33. [Autoimmune disease].
    Yoshikawa T, Kawahito Y.
    Nihon Rinsho; 2005 Apr 12; 63(4):687-90. PubMed ID: 15828238
    [Abstract] [Full Text] [Related]

  • 34. Kinase signaling cascades that modulate peroxisome proliferator-activated receptors.
    Gelman L, Michalik L, Desvergne B, Wahli W.
    Curr Opin Cell Biol; 2005 Apr 12; 17(2):216-22. PubMed ID: 15780600
    [Abstract] [Full Text] [Related]

  • 35. Cardiovascular disease and PPARdelta: targeting the risk factors.
    Muscat GE, Dressel U.
    Curr Opin Investig Drugs; 2005 Sep 12; 6(9):887-94. PubMed ID: 16187688
    [Abstract] [Full Text] [Related]

  • 36. PPARs: fatty acid sensors controlling metabolism.
    Poulsen Ll, Siersbæk M, Mandrup S.
    Semin Cell Dev Biol; 2012 Aug 12; 23(6):631-9. PubMed ID: 22273692
    [Abstract] [Full Text] [Related]

  • 37. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
    Ahmed W, Ziouzenkova O, Brown J, Devchand P, Francis S, Kadakia M, Kanda T, Orasanu G, Sharlach M, Zandbergen F, Plutzky J.
    J Intern Med; 2007 Aug 12; 262(2):184-98. PubMed ID: 17645586
    [Abstract] [Full Text] [Related]

  • 38. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
    Libby P, Plutzky J.
    Am J Cardiol; 2007 Feb 19; 99(4A):27B-40B. PubMed ID: 17307056
    [Abstract] [Full Text] [Related]

  • 39. Evolution of peroxisome proliferator-activated receptor agonists.
    Chang F, Jaber LA, Berlie HD, O'Connell MB.
    Ann Pharmacother; 2007 Jun 19; 41(6):973-83. PubMed ID: 17519293
    [Abstract] [Full Text] [Related]

  • 40. Review: Effects of PPAR activation in the placenta and the fetus: implications in maternal diabetes.
    Jawerbaum A, Capobianco E.
    Placenta; 2011 Mar 19; 32 Suppl 2():S212-7. PubMed ID: 21194748
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.